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Background: To assess if photobiostimulation (PBS) alleviates pain intensity/duration and swelling after implant 
surgery.
Material and Methods: Sixty subjects (27 male and 33 female, with a mean age of 47,13 ± 8.05 years) were included 
and randomly assigned to experimental group (implant surgery and photobiostimulation), placebo group (implant 
surgery and simulated photobiostimulation) and control group (implant surgery only). Inclusion criteria: subjects 
older than 20 years, with a healthy oral mucosa and requiring implant surgery. Exclusion criteria: pregnancy, his-
tory of implant failure, light sensitivity, metabolic deseases, consumption of antibiotics or corticosteroids in the 
last two weeks, smokers and alcohol drinkers. Patients reported the pain experienced by using a numeric rating 
scale (NRS) at 2 hours, 6 hours, 12 hours, 24 hours and from day 2 to 7. Swelling score was assessed by linear 
measurements and type and number of analgesic drugs within each time-point were recorded on a spreadsheet. 
Data of pain and amount of swelling were compared among the three groups by using the Kruskal-Wallis H Test 
and post-hoc comparisons tests.
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Introduction
Dental implant therapy has revolutionized the treatment 
of all forms of edentulism (1). However, specific side 
effects have been reported after surgical procedure for 
dental implant placement such as bleeding, pain, swell-
ing, paresthesia, nerve damage, infection and implant 
failure (2-4). Preventing or reducing the risk of inflam-
mation after implant surgery become fundamental in 
order to reduce pain, swelling, and infection. In this 
respect, clinicians use similar drugs for different treat-
ments and there is no general consensus to prescribe the 
drugs based on the patient’s health status (5,6).
Photobiostimulation is a side effects-free therapy with 
several applications in medicine and modern dentistry 
(7-9). It uses low-powered light within the red to near-
infrared range (wavelengths from 632 to 1064 nm) to 
induce biological reaction. Previous studies demon-
strated that photobiostimulation can effectively acceler-
ate healing and pain relief through reduction of media-
tors and inflammatory cells and increased endorphin, 
respectively (10). Moreover, it seems to reduce orth-
odontic pain on two levels: 1) by inhibiting the release 
of arachidonic acid, which reduces the levels of pros-
taglandin E2 (11,12) and 2) by provoking the release of 
beta-endorphin which induces an effective analgesic re-
action (13,14). In this respect, a recent well-conduceted 
trials confirmed that photobiostimulation can be used 
to reduce the severity and duration of pain after dental 
implant surgery (15). Also, it can reduce facial swelling 
and accelerate wound healing (15). However, more high 
quality randomized clinical trials (RCTs) are needed 
confirm or reject these findings.
In this respect, the aim of the present randomized 
clinical trials was to assess the effectiveness of photo-
biostimulation in controlling and/or reducing pain and 
swelling after dental implant surgery by using the spec-
tral technology-based ATP38® device (Biotech Dental, 
Allée de Craponne, Salon de Provence, France).
Material and Methods 
This randomized, with 3 parallel groups (1:1:1), single 
operator, clinical trial was approved by the ethics com-
mittee of the Faculty of Medicine at the Milano-Bicocca 
University (protocol n. 11/17) and was conducted in ob-
servance of the Declaration of Helsinki. Subjects were 
selected and treated between March 2017 and April 2019 
and all patients signed an appropriate informed consent.
- Human subjects
Sixty patients were selected from a larger pool of sub-
jects (283) who needed implant surgery in a private 
dental clinic in Bergamo (Italy). Study power was in-
vestigated taking into account data obtained by a re-
cent study (14) demonstrating a difference of 2 points 
in the pain experienced 24 hours after implant surgery 
between photobiostimulation and control group, mea-
sured via visual analogue scale (VAS).  A sample size 
of 54 participants (18 for each groups) was considered 
sufficient to obtain 80% power at a 95% confidence in-
terval, however, to balance for potential incompleteness 
of data, we decided to include 20 subjects in each group 
(tested, control and placebo).
Patients were enrolled based on the following criteria: 
subjects older than 20 years, with a healthy oral mu-
cosa and requiring implant surgery. Exclusion criteria: 
pregnancy history of implant failure, light sensitivity, 
metabolic deseases, assumption of antibiotics or corti-
costeroids in the last two weeks, smokers and alcohol 
drinkers. A randomized balanced block protocol using 
sex and age as stratification factors was performed to 
randomly allocate subjects to receive implant surgery 
plus administration of LLLT (experimental group, 20 
subjects), implant surgery only (control group, 20 sub-
jects) and implant surgery with simulated administra-
tion of LLLT (placebo group, 20 subjects). For ran-
domization purposes, SPSS Statistics software (IBM 
Corporation, Armonk, USA) was used to generate an 
allocation sequence.
Despite some patients reported multiple edentulia, they 
were enrolled in this study to underwent a single den-
tal implant surgery. Each dental implant was inserted 
by Cone-beam computed tomography (CBCT) guided 
surgery (iCAT CBCT Unit, Imaging Sciences Interna-
tional, Hartfield, PA, USA), in particular a 3d printed 
surgical guide (Formlabs SLA 3D printer, Somerville, 
MA, USA) was created for each patient in order to stan-
dardized the surgical procedure. Data score of pain and 
swelling were recorded only after the first single im-
plant surgery in those patients.
- Intervention
After implant surgery was performed, patients in the 
Results: Pain in the experimental group was less compared to controls and placebo group, at each time intervals (p < 
0.001) as well as the maximum pain score (experimental group: median = 2, interquartile range 2-3; control group: me-
dian = 8, interquartile range 3,75-9; placebo group: median = 8, interquartile range 6,25-9). Swelling was almost insig-
nificant in the experimental group (maximum value = 1, interquartile range 0-2,75, at 24 hours) compared with control 
(maximum value = 6, interquartile range 5-8,75, at 24 hours) and placebo (maximum value = 6, interquartile range 5-8, 
at 24 hours). Subjects in the experimental group assumed less analgesics compared to both controls and placebo groups.
Conclusions: Photobiostimulation is an effective method to reduce pain intensity/duration and swelling after implant surgery.
Key words: LLLT, photobiostimulation, pain, implant surgery.
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experimental group received Photobiostimulation by 
using the ATP38® (Biotech Dental, Allée de Craponne, 
Salon de Provence, France). This device features a 
multi-panels system emitting cold polychromatic lights 
with a combination of wavelengths from 450 to 835 nm 
depending on the field of action, i.e., the part treated and 
the therapeutic indication (healing, anti-inflammatory, 
and analgesic effect) (Fig. 1).
and to control chemical plaque by using chlorhexidine 
mouthwash (0.12%) for a period of two weeks. Anal-
gesics were not prescribed but could be used in case 
of acute pain, however patients must have reported the 
type and number of analgesic drugs taken within each 
time-point (see below).
- Assessment of pain, swelling and possible drugs (an-
algesic) assumption
All subjects were instructed to describe the intensity 
of pain experienced by using a numeric rating scale 
(NRS), raging from 0 to 10, at specific time-points i.e., 
2 hours, 6 hours, 12 hours, 24 hours and from day 2 
to 7 (14,16). The assessment of facial swelling was per-
formed by using linear measurements (15) at 24 hours 
and from day 2 to 7 after surgery. Moreover, type and 
number of analgesic drugs within each time-point were 
recorded on a spreadsheet. The procedure of data col-
lection and assessment of facial swelling was entrusted 
to another operator who was blinded about the three 
groups of the study (A.L.)
- Statistical analysis
The Shapiro-Wilk test was used to investigate the nor-
mal distribution of the data set. As data of pain and 
swelling were not normally distributed, inferential 
statistics was performed for these two outcomes using 
non-parametric tests. Kruskal-Wallis H Test was used 
to assess if there were differences 1) in the maximum 
pain and in the pain experienced at each time inter-
val among experimental, control and placebo groups 
and 2) in the amount of swelling among the three 
groups. Post-hoc comparisons were performed using 
the Dunn’s multiple comparison test. As data from 
drug assumptions were normally distributed, the one-
way analysis of variance (ANOVA) was performed to 
verify any statistical significance in the assumption of 
analgesic among the three groups investigated with 
Bonferroni’s test used for assessing multiple compari-
sons between groups.
Results
In the present randomized clinical trial we did not face 
with drop-out, thus the final sample consisted of 60 pa-
tients, 27 male and 33 female, with a mean age of 47.13 
± 8.05 years. The demographic and clinical characteris-
tics of the sample of the study are shown in Table 1, also 
the CONSORT flowchart is reported in Fig. 2.
Fig. 1: The ATP38® (Biotech Dental, Allée de Craponne, Salon de 
Provence, France) used in this study to perform photobiomodulation.
For the purpose of the present investigation, the anal-
gesic module was selected according to the manufac-
turer instructions. Irradiation parameters were different 
for each type of cold light source (total duration = 730 
seconds): blue light (wavelength 470 nm, duration 676 
seconds out of total 730 seconds, fluency 9 joule/cm2, 
frequency 70 hertz), green light (wavelength 525 nm, 
duration 544 seconds out of total 730 seconds, fluency 
3 joule/cm2, frequency 70 hertz), red light (wavelength 
620 nm, duration 730 seconds out of total 730 seconds, 
fluency 6 joule/cm2, frequency 70 hertz), deep red light 
(wavelength 680-760 nm, duration 721 seconds out of 
total 730 seconds, fluency 18 joule/cm2, frequency 70 
hertz) and infrared  light (wavelength 800-835 nm, du-
ration 655 seconds out of total 730 seconds, fluency 12 
joule/cm2, frequency 70 hertz). The Photobiostimula-
tion procedure was entrusted to a single operator (G.C.).
All patients were recommended to take Azithromycin 
500 mg (Pfizer. Latina, Italy) once daily for three days 
i.e., from the day before to the day after implant surgery 





group (n=20) Significance*characteristics Sample (n=60)
Gender: male/female 27/33 11-Sept 9-Nov Jul-13 NS
Age, y: mean (SD) 47.13 (8.05) 44.15 (8.48) 50.15 (7.58) 47.10 (7.28) NS
Jaw surgery: sup/inf 18/42 Jun-14 Jul-13 May-15 NS
Experimental group = implant surgery plus photobiostimulation; Control group = implant surgery 
only; Placebo group =  implant surgery plus simulated photobiomodulation.
 *p value set as ≤ 0.05. and assessed by paired t test or chi-square test. NS = not significant
Table 1: Demography, clinical characteristics and descriptive statistics of the study sample.
e280
Med Oral Patol Oral Cir Bucal. 2020 Mar 1;25 (2):e277-82. Photobiostimulation for alleviation of side effects after implant surgery
Fig. 2: CONSORT flowchart.
Time Schedule
Experimental Control Placebo
Significance*group a group b group c
Median (IQR) Median (IQR) Median (IQR)
Maximum Pain Score 2 (2-3) b-c 8 (3,75-9) a 8 (6,25-9) a < 0.001
2 hours 2 (2-3) b-c 8 (3,75-9) a 8 (6,25-9) a < 0.001
6 hours 1 (0-1) b-c 2 (1-3) a-c 3 (1,25-5) a-b < 0.001
12 hours 0 (0-0) b-c 4.5 (2-7) a 5.5 (3-7) a < 0.001
24 hours 0 (0-0) b-c 4 (0,25-5) a 4.50 (1,25-5) a < 0.001
2 days 0 (0-0) b-c 1 (0-2) a 1 (0-2) a < 0.001
3 days 0 (0-0) c 0 (0-0) c 0 (0-1,75) a-b < 0.05
4 days 0 (0-0) 0 (0-0) 0 (0-0) NS
5 days 0 (0-0) 0 (0-0) 0 (0-0) NS
6 days 0 (0-0) 0 (0-0) 0 (0-0) NS
7 days 0 (0-0) 0 (0-0) 0 (0-0) NS
Experimental group = implant surgery plus photobiostimulation; Control group = implant surgery only; Placebo group =  implant 
surgery plus simulated photobiomodulation.
* p value set as ≤ 0.05. and assessed by Kruskal-Wallis H Test
a-b-c= Codification for significance of post-hoc comparisons, according to the Dunn’s multiple comparison test. IQR = 
interquartile range
Fig. 3 shows the levels of pain reported in each group at 
each time point. In particular, in the experimental group 
pain experienced is less and decrease even before com-
pared to subjects in both control and placebo groups as 
confirmed by the Kruskal-Wallis H test and the Dunn’s 
multiple comparison test (Table 2). In this respect, the 
maximum pain experienced in the experimental group 
was, in median value, 2 point on the NRS while it 
reached 8 point in both control and placebo group.
The level of swelling reported by patients was found to 
statistically differ among the three groups (Table 3), ac-
cording to the Kruskal-Wallis H test.
In this respect, swelling was almost insignificant in the ex-
perimental group were the maximum median value was 
1 at 24 hours after surgery; on the contrary, both control 
and placebo group reported a median value of swelling of 
6 at 24 hours which gradually decrease up to day 4, i.e. 
when the median values reported was 0. Thus, no differ-
ences were found between control and placebo groups, as 
assessed by the Dunn’s multiple comparison test.
Finally, the assumption of drugs differs among the three 
groups, according to the ANOVA on-way analysis of 
variance (Table 4).
Fig. 3: Graph showing levels of pain reported in each group of sub-
jects at each time point.
Table 2: Maximum pain score and pain experienced at each time schedule, assessed via Numeric Rating Scale (NRS).
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In particular, subjects in the experimental group report-
ed a total mean value of analgesics (pills) of 0.2, while 
the control and placebo groups reported respectively a 
mean value of 2.20 and 2.55. Thus, no differences were 
found between control and placebo groups, as assessed 
by the Bonferroni multiple comparison tests.
Discussion
Edema and swelling are the most frequent side effects 
reported after dental implant surgery. As consequence, 
the management of these side effects becomes crucial in 
order to enhance the patients’ post-surgical experience 
and increase their comfort (17).
The beneficial rule of photobiostimulation in reducing 
pain after surgical procedure is still controversial with 
some studies reporting no significant advantages (18,19) 
and other studies reporting a significant effectiveness 
of photobiostimulation in reducing pain compared to 
control group (15,17). In this respect, Safdari et al. (15) 
reported a significant reduction in pain duration and 
also pain intensity at 12, 24, 48, 72 hours after implant 
surgery in the laser group compared with control group.
In the present study, we found a significant reduction in 
the pain experienced in the experimental group (implant 
surgery plus photobiomodulation) compared to both 
control (implant surgery only) and placebo (implant 
surgery and simulated photobiomodulation) in each 
time-point up to day 3 (Table 2). According to Farrar et 
al. (20), the benchmark of clinical significant change in 
the experience of pain corresponds to a reduction/aug-
mentation of approximately two points in the NRS.  In 
this respect, the differences in maximum pain score and 
in the pain recorded at specific time points (2 hours, 12 
hours and 24 hours 3) between experimental and control 
group were equal or higher than two points on the NRS 
scale, corroborating the clinical significance of our find-
ings. As showed in Fig. 3, we also found a reduction of 
pain duration after photobiostimulation since pain re-
ported in this group completely disappeared 24 hours 
after surgery (all patients in the tested group reported 0 
value from this time-point on). As consequence of the 
reduction of pain intensity and duration, we found that 
subjects in the experimental group turned to analgesic 
drugs significantly less than subjects in the control/pla-
cebo groups for the management of post-surgical pain.
Moreover, subjects in the experimental group present-
ed a significant reduction in the score of facial swelling 
compared to both control and placebo groups, at least 
up to day 3 since, from this time-point after, swelling 
almost disappear even in the latter groups. These find-
ings would corroborate the use of photobiostimulation 
to control post-surgical swelling and could be attrib-
uted to its rule in facilitating vasodilatation, increas-
ing circulation, phagocytosis and ymphatic drainage 
(15,21-23).
One of the interesting aspects of the present study was 
the use of ATP38® to perform photobiostimulation. 
This device features a multi-panels system emitting 
Drugs assumption
Experimental Control Placebo
Significance*group a group b group c
Mean (SD) Mean (SD) Mean (SD)
24 hours 0.2 (0.5) b-c 2.20 (1.64) a 2.55 (1.60) a < 0.001
Experimental group = implant surgery plus photobiostimulation; Control group = implant surgery only; Placebo group =  implant 
surgery plus simulated photobiomodulation; SD = Standard deviation. 
* p value set as ≤ 0.05. and assessed by single factor analisys of variance tests (ANOVA)
a-b-c= Codification for significance of post-hoc comparisons, according to the Bonferroni’s multiple comparison test.
Table 4: Mean values of drugs assumption after implant surgery among each groups investigated.
Time Schedule
Experimental Control Placebo
Significance*group a group b group c
Median (IQR) Median (IQR) Median (IQR)
24 hours 1 (0-2,75) b-c 6 (5-8,75) a 6 (5-8) a < 0.001
2 days 0 (0-0,75) b-c 3.5 (2-4,75) a 3 (2-5) a < 0.001
3 days 0 (0-0) b-c 2 (0-2) a 1.5 (0,25-2) a < 0.001
4 days 0 (0-0) 0 (0-0) 0 (0-1) NS
5 days 0 (0-0) 0 (0-0) 0 (0-1) NS
6 days 0 (0-0) 0 (0-0) 0 (0-0) NS
7 days 0 (0-0) 0 (0-0) 0 (0-0) NS
Experimental group = implant surgery plus photobiostimulation; Control group = implant surgery only; Placebo group =  implant 
surgery plus simulated photobiomodulation.
* p value set as ≤ 0.05. and assessed by Kruskal-Wallis H Test. IQR = interquartile range
a-b-c= Codification for significance of post-hoc comparisons, according to the Dunn’s multiple comparison test.
Table 3: Median score of swelling from 24 hours to 7 days after implant surgery.
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cold polychromatic lights with a simultaneous combi-
nation of wavelengths that correspond to Cytochrome 
C Oxidase and Porphyrin absorption peaks (from 450 
to 835 nm); this correspondence, similar to 7 windows 
open over different depths, favours the power density, 
i.e., a strong concentration of photons to quickly deliver 
the total intended energy dose. This is called spectral 
technology.  In the light of the present findings, the 
ATP38 can be considered a valuable tool for the man-
agement of post-operative implant surgery side-effects. 
Further prospective clinical trials must be carried out 
to assess if spectral technology is more effective than 
conventional single wavelength photo-biomodulation in 
controlling post-surgical/post-treatment side-effects in 
dentistry.
In this respect, there would be two promising advantag-
es in the usage of spectral technology: 1) the procedure 
of photobiostimulation is less time-consuming since 
the device makes it possible to treat larger surfaces and 
does not require the clinicians to manually position-
ing the optical fiber tip over the interested area; 2) it 
guarantees the established energy dose on the treated 
surface eliminating the intra/inter operator error, thus 
increasing the reproducibility of the photobiostimula-
tion procedure.
The results of the present study would corroborate the 
usage of photobiostimulation, as a complementary ther-
apeutic procedure, to alleviate pain and swelling after 
implant surgery. Further studies are needed to compar-
atively assess if spectral technology is as effective as 
conventional single wavelength photobiomodulation in 
controlling post-surgical/post-treatment side-effects in 
dentistry.
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